Glucagon-like peptide-1 receptor agonists are associated with fewer venous thromboembolic events and limb complications in obese patients with chronic venous insufficiency

Lavender Micalo, Mark Archie, Vincent L Rowe, Adedunmola P Adewale, Nathan Vu Pham, Albert Li, Juan Carlos Jimenez · 2026

Read Glucagon-like peptide-1 receptor agonists are associated with fewer venous thromboembolic events and limb complications in obese patients with chronic venous insufficiency by Lavender Micalo, Mark Archie, Vincent L Rowe, Adedunmola P Adewale, Nathan Vu Pham, Albert Li, Juan Carlos Jimenez (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/PMC13383999.txt.

Description

Lavender Micalo and colleagues ask whether GLP-1 drugs link to fewer clots and leg problems in obese patients with vein disease in 2026 work. Adults aged 40 and older with chronic venous insufficiency were drawn from a large United States health network. Patients starting GLP-1 therapy were matched one to one with similar patients who did not start it.

Outcomes tracked over one and three years covered deep vein clots, lung clots, leg ulcers, skin infection, and death. People with earlier clots were excluded so new events could be judged cleanly. The matched design aims to show whether weight-loss drug therapy also protects veins, an open question the authors set out to answer.

Catalog record

CREATORLavender Micalo, Mark Archie, Vincent L Rowe, Adedunmola P Adewale, Nathan Vu Pham, Albert Li, Juan Carlos Jimenez
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE28669
LICENSEhttps://creativecommons.org/licenses/by/4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/article/MED/PMC13383999

Browse the full library · About the Tower of Babel